These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 28726352)

  • 1. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
    Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
    Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
    Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
    MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies.
    Bönisch M; Sellmann C; Maresch D; Halbig C; Becker S; Toleikis L; Hock B; Rüker F
    Protein Eng Des Sel; 2017 Sep; 30(9):685-696. PubMed ID: 28981885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
    Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
    MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG-like bispecific antibody platforms with built-in purification-facilitating elements.
    Li Y
    Protein Expr Purif; 2021 Dec; 188():105955. PubMed ID: 34416361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
    De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
    J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient production of bispecific antibody by FAST-Ig
    Koga H; Yamano T; Betancur J; Nagatomo S; Ikeda Y; Yamaguchi K; Nabuchi Y; Sato K; Teranishi-Ikawa Y; Sato M; Hirayama H; Hayasaka A; Torizawa T; Haraya K; Sampei Z; Shiraiwa H; Kitazawa T; Igawa T; Kuramochi T
    MAbs; 2023; 15(1):2222441. PubMed ID: 37339067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells.
    Asano R; Kawaguchi H; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    J Immunother; 2008 Oct; 31(8):752-61. PubMed ID: 18779744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
    Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
    MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of bispecific antibodies by structure-guided redesign of IgG constant regions.
    Iwasaki YW; Tharakaraman K; Subramanian V; Khongmanee A; Hatas A; Fleischer E; Rurak TT; Ngok-Ngam P; Tit-Oon P; Ruchirawat M; Satayavivad J; Fuangthong M; Sasisekharan R
    Front Immunol; 2022; 13():1063002. PubMed ID: 36703993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry.
    Schachner L; Han G; Dillon M; Zhou J; McCarty L; Ellerman D; Yin Y; Spiess C; Lill JR; Carter PJ; Sandoval W
    Anal Chem; 2016 Dec; 88(24):12122-12127. PubMed ID: 28193052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering bispecific antibodies with defined chain pairing.
    Krah S; Sellmann C; Rhiel L; Schröter C; Dickgiesser S; Beck J; Zielonka S; Toleikis L; Hock B; Kolmar H; Becker S
    N Biotechnol; 2017 Oct; 39(Pt B):167-173. PubMed ID: 28137467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies.
    Rajendra Y; Peery RB; Hougland MD; Barnard GC; Wu X; Fitchett JR; Bacica M; Demarest SJ
    Biotechnol Prog; 2017 Mar; 33(2):469-477. PubMed ID: 27977915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.
    Michaelson JS; Demarest SJ; Miller B; Amatucci A; Snyder WB; Wu X; Huang F; Phan S; Gao S; Doern A; Farrington GK; Lugovskoy A; Joseph I; Bailly V; Wang X; Garber E; Browning J; Glaser SM
    MAbs; 2009; 1(2):128-41. PubMed ID: 20061822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
    Shen J; Vil MD; Jimenez X; Zhang H; Iacolina M; Mangalampalli V; Balderes P; Ludwig DL; Zhu Z
    J Immunol Methods; 2007 Jan; 318(1-2):65-74. PubMed ID: 17126853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties.
    Vendel MC; Favis M; Snyder WB; Huang F; Capili AD; Dong J; Glaser SM; Miller BR; Demarest SJ
    Arch Biochem Biophys; 2012 Oct; 526(2):188-93. PubMed ID: 22230329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism.
    Liu Z; Leng EC; Gunasekaran K; Pentony M; Shen M; Howard M; Stoops J; Manchulenko K; Razinkov V; Liu H; Fanslow W; Hu Z; Sun N; Hasegawa H; Clark R; Foltz IN; Yan W
    J Biol Chem; 2015 Mar; 290(12):7535-62. PubMed ID: 25583986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
    Schoonjans R; Willems A; Schoonooghe S; Leoen J; Grooten J; Mertens N
    Biomol Eng; 2001 Jun; 17(6):193-202. PubMed ID: 11337278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.